July '16 Cardicare Egyan Quiz

25 Questions | Total Attempts: 104

SettingsSettingsSettings
Please wait...
July

Welcome to July E-Learning Test. Here is an opportunity to test your Product knowledge & Strategy. You have 20 minutes to complete this test. Please enter your Name, Emp. Code, HQ & select your State. Then press "Start" to begin the test. You can only attend this test once, hence make sure you have uninterrupted Internet connectivity. All the BestMicro Leadership Academy.


Questions and Answers
  • 1. 
    What is GFR ?
    • A. 

      Glomerular fibrosis rate

    • B. 

      Glomerular filtration ratio

    • C. 

      Glomerular filtration rate

    • D. 

      Glomerular filteration resistance

  • 2. 
    Name of the end organs in the body
    • A. 

      Heart, Kidneys, Lungs, Eyes

    • B. 

      Heart, Kidneys, Brain, Lungs

    • C. 

      Heart, Kidneys, Brain, Eyes

    • D. 

      Heart, Kidneys, Brain

  • 3. 
    CARTER Trial is for
    • A. 

      Amlodipine

    • B. 

      Cilnidipine

    • C. 

      Ramipril

    • D. 

      Metoprolol

  • 4. 
    L- Type calcium Channels are majorly present on
    • A. 

      Neurons

    • B. 

      Brain

    • C. 

      Heart and Blood Vessels

    • D. 

      Brain and Neurons

  • 5. 
    N-type calcium channels means
    • A. 

      Neural-Type calcium channels

    • B. 

      Neutral-Type calcium channels

    • C. 

      Natural-Type calcium channels

    • D. 

      Natriuretic-Type calcium channels

  • 6. 
    What is Angina Pectoris ?
    • A. 

      Severe chest pain involving pressure or squeezing, due to spasm of the coronary arteries

    • B. 

      Severe chest pain involving pressure or squeezing, due to spasm of the peripheral arteries

    • C. 

      Severe chest pain involving pressure or squeezing, due to spasm of the carotid arteries

    • D. 

      Chest pain due to any reason is called Angina Pectoris

  • 7. 
    Clopidogrel is a ________agent
    • A. 

      Antiplatelet

    • B. 

      Antihypertensive

    • C. 

      Antihyperlipidemic

    • D. 

      Diuretic

  • 8. 
    Select the Correct Statement
    • A. 

      Ramipril is used for the management of oedema

    • B. 

      Ramipril decrease risk of stroke , MI and CV deaths by 25%

    • C. 

      Ramipril blocks AT 1 Receptors and shows antihypertensive effects

    • D. 

      Ramipril Blocks Beta Recetors on Heart and Blood vessels managing arrythmia

  • 9. 
    What is HRV Prameter
    • A. 

      Heart Rate Variability Parameters

    • B. 

      Heart Rate Ventilation Parameters

    • C. 

      Heart Response Volume Parameters

    • D. 

      Heart Response Variability Parameters

  • 10. 
    What is Hypokalemia?
    • A. 

      Deficiency of Calcium in the Bloodstream

    • B. 

      Deficiency of Sodium in the Bloodstream

    • C. 

      Deficiency of Nitric Oxide in the Bloodstream

    • D. 

      Deficiency of Potassium in the Bloodstream

  • 11. 
    RAAS System involves the following
    • A. 

      Renin, Proton Pumps & Angiotensinogen Converting Enzyme

    • B. 

      Renin, Angiotensin, Epinephrine & Angiotensinogen Converting Enzyme

    • C. 

      Renin, Angiotensin, Aldosterone & Thromboxane

    • D. 

      Renin, Angiotensin, Aldosterone & Angiotensinogen Converting Enzyme

  • 12. 
    Choose the Correct set - AT -1 Receptors are present on
    • A. 

      Heart, Blood vessels, Kidney, Adrenal Cortex, Eyes and Brain

    • B. 

      Heart, Blood vessels, Kidney, Adrenal Cortex, Lungs and Brain

    • C. 

      Heart, Blood vessels, Kidney, Adrenal Cortex, Lungs and Eyes

    • D. 

      Heart, Blood vessels, Kidney, Eyes, Lungs and Brain

  • 13. 
    Atherosclerosis leads to
    • A. 

      Coronary Heart Disease

    • B. 

      Carotid Artery Disease

    • C. 

      None of the above

    • D. 

      Both Option -1 & 2

  • 14. 
    Role of Arbitel -AM in Diabetic Hypertensives
    • A. 

      Combination helps to decrease insulin sensitivity and Decreases End Organ Damage

    • B. 

      Combination helps to improve insulin sensitivity and Decreases End Organ Damage

    • C. 

      Combination helps to improve insulin sensitivity and has no role End Organ Damage

    • D. 

      Combination helps to improve insulin resistance and Decreases End Organ Damage

  • 15. 
    What is Ghost Matrix Technology ?
    • A. 

      Technology for betterment of the rate of Drug Realease, Dissolution and Bioavailability

    • B. 

      Technology for reducing of the Drug's Adverse reactions

    • C. 

      Technology for improving survival rate of the patients

    • D. 

      Technology for improving renal oxygenation status of the patients

  • 16. 
    Combination of Hopace MT is used for
    • A. 

      Reducing Renin release & Cardioprotection

    • B. 

      Volume Reduction

    • C. 

      Diabetes Control and insulin sensetivity

    • D. 

      All of the above

  • 17. 
    Chlorthalidone in Arbitel -CT helps in
    • A. 

      Has better response rates versus ARB's

    • B. 

      Reduces new onset of LVH

    • C. 

      To Achieve Target B.P in 88% Cases

    • D. 

      Blocks both -L and N Types of Calcium Channels

  • 18. 
    What is Metabolic Syndrome?
    • A. 

      A cluster of complications like diabetes, abdominal obesity, high cholesterol and High Blood Pressure

    • B. 

      A cluster of complications like diabetes, abdominal obesity, high cholesterol and Edema

    • C. 

      A cluster of complications like abdominal obesity, high cholesterol and Edema

    • D. 

      A cluster of complications like abdominal obesity, high cholesterol and High Blood Pressue

  • 19. 
    What is the role of Ramirpil in Post MI Patients
    • A. 

      Reduces fluid accumulation

    • B. 

      Counteracts the hypertension dependent lipid abnormalities

    • C. 

      Reduces coronary and cerebrovascular events

    • D. 

      All of the above

  • 20. 
    Choose the correct brand used for MI,CAD& ACS
    • A. 

      Astin -CV

    • B. 

      Astin -D

    • C. 

      Astin

    • D. 

      Fibrovas

  • 21. 
    Atorvastatin is a _______
    • A. 

      HMG CoA Reductase Activator

    • B. 

      HMG CoA Reductase Modulator

    • C. 

      HMG CoA Reductase Agonist

    • D. 

      HMG CoA Reductase Inhibitor

  • 22. 
    What is PCI ?
    • A. 

      Peripheral coronary intervention

    • B. 

      Percutaneous carotid intervention

    • C. 

      Percutaneous coronary intervention

    • D. 

      None of the above

  • 23. 
    What is the role of Vitamin D in CVD's
    • A. 

      Reduces statin induced myalgia

    • B. 

      Aids in preventing Stroke

    • C. 

      Helps in managemnet of Dyslipidemia

    • D. 

      All of the above

  • 24. 
    Oedema means
    • A. 

      Accumulation of salt collecting in the cavities or tissues of the body

    • B. 

      Accumulation of Watery fluid collecting in the cavities or tissues of the body

    • C. 

      Accumulation of ACE collecting in the cavities or tissues of the body

    • D. 

      Accumulation of Lactic Acid in the cavities or tissues of the body

  • 25. 
    Which study is for Ranolazine
    • A. 

      ONTARGET

    • B. 

      EUTOPIA

    • C. 

      CARISA

    • D. 

      HOPE

Back to Top Back to top